Skip to main content


At JDRF, we are dedicated to making a positive impact on the lives of everyone living with type 1 diabetes by actively participating in advocacy work.

Two men dressed in smart suits discussing JDRF's policy and advocacy projects, and their philanthropy programme

Our approach to policy

Our goal is to shape healthcare consultations regarding access to new treatments and technology. You can learn more about our efforts in influencing policies that affect people with type 1 by exploring our comprehensive policy papers.

Collaborating with healthcare providers

A crucial aspect of our work involves actively engaging and responding to consultations from public bodies such as the National Health Service (NHS), the National Institute for Health and Care Excellence (NICE), and the UK and Devolved Governments.

We contribute real-life case studies, gather insights from academic experts and healthcare professionals, ensuring that the unique needs and challenges of people with type 1 diabetes are taken into account when making healthcare decisions and developing guidelines.

We regularly publish our policy positions on key issues related to type 1 diabetes. These positions are based on expert research, input from the type 1 community, and the valuable insights provided by individuals and professionals in the field. By making our positions publicly available, we aim to raise awareness and advocate for necessary changes that will enhance the lives of everyone living with type 1 diabetes.

Collaborating with Government

We actively engage in efforts to influence government policies through briefings and meetings with Parliamentarians. By working closely with policymakers, we strive to ensure that the concerns and voices of the type 1 diabetes community are heard and addressed.

Through strategic advocacy, we aim to drive policy changes that enhance access to innovative treatments, support research funding, and improve overall healthcare for all individuals with type 1 diabetes.

Related news

Read more
Policy and advocacy
1 February 2024

Our letter to the producers of Would I Lie to You?

We wrote to the producers of the hit BBC show after they broadcast jokes about type 1 diabetes.

Read more
A doctor talking to a young woman holding a pen
Policy and advocacy
23 January 2024

Parliamentary Inquiry calls for urgent action on type 1 and disordered eating

Parliamentary Inquiry chaired by our Global Health Ambassador, Rt. Hon Theresa May MP and Sir George Howarth MP, highlights the risks of type 1 diabetes-related eating disorders (T1DE).

Read more
Hybrid closed loop technology
Research Treatment research Treatments Type 1 technology
19 December 2023

NICE Approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales

In an historic advancement in the treatment of type 1 diabetes, the National Institute for Health and Care Excellence (NICE) today approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales.

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Policy and advocacy Treatment research Treatments Type 1 technology
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Join our social communities